NCT00802828已完成1 期
Randomized, 2-Way Crossover, Bioequivalence Study of Famotidine 40 mg Tablets Administered as 1 x 40 mg Tablet in Healthy Subjects Under Fasting Conditions
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 44
- 主要终点
- Bioequivalence was assessed based on the pharmacokinetic variables, Cmax, AUCO-t and AUCO-infinity
研究概览
简要总结
Compare the rate and extent of absorption of famotidine 40 mg tablets, administered as 1 x 40 mg tablet under fasting conditions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •healthy men or women 18 years of age or older
- •body mass index below 30.0 kg/m2
- •willing to participate and sin a copy of the informed consent form
排除标准
- •recent history of drug or alcohol addiction or abuse
- •pregnant or lactating women
- •history of allergic response to heparin, famotidine, other H2-receptor antagonists, or other related drugs
- •evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant
- •recipient of any drugs as part of a research study within 30 days prior to study dosing
研究组 & 干预措施
Test Product
Active Comparator
干预措施: Famotidine Tablets, 40 mg (Drug)
Reference Product
Active Comparator
干预措施: Famotidine Tablets, 40 mg (Drug)
结局指标
主要结局
Bioequivalence was assessed based on the pharmacokinetic variables, Cmax, AUCO-t and AUCO-infinity
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed ConditionsBioavailabilityNCT00803192Perrigo Company44
招募中
Unknown
Bioequivalence study of famotidine 40 mg tablets produced by Actoverco pharmaceutical companyThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20240804062647N1?Actoverco Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of famotidine 40 mg tabletIRCT20230222057495N12Ramopharmin Pharmaceutical Company24
已完成
不适用
Bioequivalance study of Famotidine 40 mgIRCT20200513047423N5Fatak chemie pars Pharmacy24
尚未招募
不适用
Bioequivalance study of Famotidine 40 mgSubject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.IRCT20200513047423N9Iran Daru Pharmaceutical Company24